CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating expenses:
Research and development	$ 825,700	$ 372,600
General and administrative	1,137,600	1,448,500
Total operating expenses	1,963,300	1,821,100
Loss from operations	(1,963,300)	(1,821,100)
Other expenses, net:
Interest expense, net	(1,400)	(755,100)
Change in warrant liability	0	(1,894,700)
Loss on extinguishment of debt	0	(25,050,900)
Loss before income taxes	(1,964,700)	(29,521,800)
Income taxes	(2,400)	(2,300)
Net loss	(1,967,100)	(29,524,100)
Accrued dividends on Series B Preferred stock	(539,800)	(213,300)
Deemed dividend on Series B Preferred Units	(111,100)	(256,200)
Net loss attributable to common stockholders	$ (2,618,000)	$ (29,993,600)
Basic and diluted net loss attributable to common stockholders per common share	$ (.51)	$ (19.23)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share	5,097,832	1,559,483
Comprehensive loss	$ (1,967,100)	$ (29,524,100)